Editorial desk · PT-141
Contact the PT-141 Editorial Desk
For corrections, sourcing questions, and editorial correspondence about the bremelanotide literature.
Editorial Correspondence
Use the form below to reach the editors of Medicine PT-141 about the published record on PT-141 (bremelanotide). We welcome corrections, citation queries, and notes on studies we should add — particularly anything that sharpens the accuracy of a measured value or its source.
What this desk does not do: it does not provide medical advice, it does not recommend or supply any compound, and it does not answer requests to purchase, source, or price anything. Bremelanotide is a prescription drug for one approved indication; questions about whether it is appropriate for an individual belong with a licensed prescriber, not with an editorial publisher.
What to Expect
This is an editorial inbox, not a clinical or commercial one. If you write about a specific number on the site, point us to the page and the figure and we will check it against the cited source. If a citation has been updated, retracted, or annotated since publication, tell us — we treat the citation register as a living document and would rather correct the record than defend it.
We read everything and reply selectively. There is no account, no order, and no consultation attached to this form — only the editorial conversation about what the PT-141 literature actually shows.